Home Healthcare Healthcare Services Healthcare Logistics Market

Healthcare Logistics Market Size, Share & Trends Analysis Report By Service (Transportation Services, Freight Forwarding Services, Warehousing and Distribution, Value-added Services, Others), By Industry (Pharmaceutical, Biopharmaceutical, Medical Devices), By Supply Chain (Cold Chain, Non-Cold Chain), By End User (Pharmaceutical & Biotechnological Companies, Medical Device Companies, Healthcare Facilities, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 06, 2026 | Author: Debashree Bora | Format:

Healthcare Logistics Market Size & Growth Analysis

The global healthcare logistics market size was valued at USD 102.71 billion in 2025 and is projected to grow from USD 108.18 billion in 2026 to USD 163.90 billion by 2034, registering a CAGR of 5.33% during the forecast period from 2026 to 2034. North America dominated the healthcare logistics market with a market share of 36.8% in 2025.

Healthcare logistics involves the transportation, storage, and distribution of medicines, medical devices, vaccines, and other healthcare products. It ensures that critical products reach hospitals, pharmacies, clinics, and patients safely and on time. Temperature-sensitive products such as vaccines and biologics require specialized packaging, storage, and transportation to maintain their quality. Technologies such as real-time tracking, automated inventory systems, and temperature monitoring are improving supply chain visibility and efficiency. As healthcare supply chains become more complex, reliable logistics services are becoming essential for timely and safe healthcare delivery.

Healthcare Logistics Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 102.71 Billion
2026 Market Size
USD 108.18 Billion
2034 Projected Market Size
USD 163.90 Billion
Forecast Period
2026–2034
Base Year
2025
Market CAGR (2026–2034)
5.33%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
36.8%
Fastest-Growing Region
Asia Pacific
Asia Pacific CAGR (2026–2034)
10.6%

Segment Insights

By Service
Leading Segment
Transportation Services
Market Share in 2025 38.6%
By Industry
Fastest-Growing Segment
Biopharmaceutical
CAGR (2026–2034) 10.2%
By Supply Chain
Leading Segment
Non-Cold Chain
Market Share in 2025 55.7%
By End User
Fastest-Growing Segment
Pharmaceutical & Biotechnological Companies
CAGR (2026–2034) 9.4%
Healthcare Logistics Market Size

Download a Free Sample To learn more about this report.

Healthcare Logistics Market Dynamics

01

Biopharmaceutical Manufacturing Expansion and Cold Chain Infrastructure Strengthen Healthcare Logistics

Biopharmaceutical manufacturing expansion creates demand for specialized logistics across raw materials, active ingredients, and finished therapies. WHO notes that biological products can be sensitive to heat, light, and environmental changes, making controlled storage and transportation important for maintaining product quality. For example, manufacturers can use qualified cold-chain providers to move monoclonal antibodies and other biologics between production facilities, distribution centers, and hospitals. The need for validated handling across these stages expands shipment requirements and strengthens demand for specialized healthcare logistics services.

Pharmaceutical cold chain infrastructure strengthens the supply capacity of logistics providers handling temperature-sensitive medicines and vaccines. WHO states that almost all vaccines used in immunization programs are licensed for storage and distribution at 2°C to 8°C, creating a defined requirement for temperature-controlled logistics. WHO's 2026 logistics tools also support forecasting requirements for vaccine storage capacity, transportation resources, and cold-chain systems across national programs. For example, refrigerated warehouses, qualified vehicles, and temperature-controlled packaging allow distributors to move vaccines from manufacturers to hospitals and vaccination centers without compromising product quality.

01

High Cold Chain Costs and Infrastructure Gaps Restrain Market Expansion

High cold chain logistics costs increase expenses for temperature-controlled storage, specialized packaging, refrigerated transport, and continuous monitoring of healthcare products. The resulting cost burden can limit service adoption among smaller healthcare organizations and restrict the expansion of temperature-sensitive healthcare logistics.

Limited cold chain infrastructure can create gaps in refrigerated storage, transportation, and temperature monitoring for medicines, vaccines, and biologics. These infrastructure limitations can increase delivery risks and operating costs, restricting healthcare logistics coverage in underserved and remote markets.

01

Healthcare Logistics Creates Opportunities in Clinical Trials and Reverse Logistics

Clinical research organizations, pharmaceutical companies, and specialized logistics providers can offer transportation, storage, and handling for investigational medicines, biological samples, and trial materials. World Courier notes that modern clinical trials involve a median of 40 sites and 1,202 participants, creating opportunities for specialized logistics contracts, packaging, storage, and sample transportation.

Healthcare logistics providers, pharmaceutical distributors, and medical-device companies can develop services for product returns, recalled medicines, returned devices, and asset recovery. UPS generated $11.2 billion from its global healthcare portfolio in 2025 and provides reverse-logistics services for medical devices and pharmaceutical returns, creating revenue avenues through returns management, collection, and specialized healthcare logistics.

01

Workforce Shortages and Fragmented Data Systems Hinder Healthcare Logistics Growth

Healthcare logistics requires specialized expertise in pharmaceutical handling, inventory control, regulatory procedures, and time-sensitive distribution. Shortages of qualified personnel can increase operational pressure and make it difficult for logistics providers to expand services across new healthcare networks. Logistics providers often need to connect with hospitals, pharmacies, manufacturers, distributors, and healthcare platforms using different data systems. Poor interoperability can limit real-time coordination and make it harder to optimize inventory and delivery operations at scale.

Healthcare Logistics Market Segmentation Analysis

By Service

The transportation services segment dominated the healthcare logistics market with a market share of 38.6% in 2025, supported by the continuous movement of medicines, biologics, medical devices, and clinical supplies between manufacturing sites, distribution hubs, healthcare facilities, and pharmacies. Specialized transport arrangements are particularly important where shipment timing, product integrity, and regulatory handling requirements must be maintained throughout transit.

The value-added services segment is expected to register the fastest CAGR of 10.3% during the forecast period 2026–2034, driven by greater use of packaging, labeling, inventory coordination, serialization support, and shipment monitoring beyond basic transport and storage. Warehousing and distribution remain important for stock positioning and order fulfillment, while freight forwarding supports cross-border movement and customs coordination. Other services address specialized operational requirements within healthcare supply networks.

Healthcare Logistics Market Size By Segments

Request Customizationto receive a tailored report.

By Industry

The pharmaceutical segment dominated the healthcare logistics market with a market share of 43.5% in 2025, reflecting the large and recurring movement of prescription drugs, over-the-counter medicines, active ingredients, and finished formulations through tightly controlled distribution networks. Product traceability, storage conditions, and timely replenishment make logistics a core part of pharmaceutical operations.

The biopharmaceutical segment is expected to grow at the fastest CAGR of 10.2% during the forecast period 2026–2034, supported by the handling needs of biologics, vaccines, cell-based products, and other therapies that often require stricter temperature and shipment controls. Medical devices continue to require coordinated distribution for equipment, implants, diagnostic products, and hospital supplies across multiple care settings.

By Supply Chain

The non-cold chain segment dominated the healthcare logistics market with a market share of 55.7% in 2025, supported by the large volume of pharmaceuticals, consumables, and medical devices that can be transported and stored under standard controlled conditions without continuous refrigeration. Established ambient distribution networks allow these products to move efficiently across wholesalers, hospitals, pharmacies, and other care channels.

The cold chain segment is expected to register the fastest CAGR of 10.5% during the forecast period 2026–2034, supported by the wider distribution of biologics, vaccines, specialty medicines, and temperature-sensitive therapies that require refrigerated or frozen storage throughout the logistics cycle.

By End User

The pharmaceutical & biotechnological companies segment dominated the healthcare logistics market with a market share of 45.8% in 2025 and is also expected to grow at the fastest CAGR of 9.4% during the forecast period 2026–2034. These companies rely on logistics networks for raw-material movement, clinical supplies, finished-product distribution, temperature-controlled shipments, and regulatory-compliant delivery across domestic and international markets.

Healthcare facilities require dependable replenishment of medicines, devices, and consumables to maintain uninterrupted patient care, while medical device companies depend on logistics for equipment deployment, replacement parts, and hospital distribution. Other end users rely on healthcare logistics for specialized storage, transport, and fulfillment requirements.

Healthcare Logistics Market Share By Segments

Speak to an Analystto discuss market opportunities.

Healthcare Logistics Market Regional Analysis

North America Healthcare Logistics Market Analysis

North America dominated the global healthcare logistics market with a 36.8% share in 2025. The region benefits from advanced healthcare infrastructure, established pharmaceutical and medical-device industries, and sophisticated logistics networks supporting the movement of medicines, medical supplies, and temperature-sensitive healthcare products.

The U.S. healthcare logistics market is supported by the U.S. FDA’s Drug Supply Chain Security Act framework, which requires interoperable electronic tracing of prescription drugs at the package level, with enhanced distribution-security requirements being implemented to strengthen pharmaceutical supply-chain visibility and security.

The Canada healthcare logistics market is supported by Health Canada’s 2024–2028 Health Product Shortages Plan, which is being implemented over four years to strengthen medicine and medical-device supply resilience, while the government’s 2026 Pharmaceutical and Life Sciences Sector Task Force focuses on reducing supply-chain vulnerabilities and strengthening domestic pharmaceutical capacity.

North America Healthcare Logistics Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Healthcare Logistics Market Analysis

Asia Pacific is the fastest-growing region in the healthcare logistics market, with a projected CAGR of 10.6% during the forecast period 2026–2034. Expanding healthcare infrastructure, growing pharmaceutical manufacturing, increasing healthcare access, and rising cross-border movement of medicines and medical products are supporting regional market growth.

The Japan healthcare logistics market is supported by the Ministry of Health, Labour and Welfare’s aim to establish by 2030 a domestic production system capable of continuously supplying the necessary quantities of β-lactam antibiotics even when overseas raw-material supplies are disrupted, with government support also extending to pharmaceutical storage facilities.The China healthcare logistics market benefits from the country’s 2025–2030 pharmaceutical digital-transformation plan, which targets deeper digital integration across the pharmaceutical industry supply chain through 2030, while the Healthy China 2030 framework calls for modern medicine-distribution networks and wider application of modern logistics technologies.

The India healthcare logistics market is supported by the country’s target of achieving USD 50 billion in pharmaceutical exports by 2030, according to the Ministry of Commerce and Industry, while the government has also emphasized investments in overseas markets, local value addition, and last-mile delivery to build resilient, globally integrated healthcare supply chains.

Europe Healthcare Logistics Market Analysis

Europe accounted for a 28.4% share of the global healthcare logistics market in 2025. Established healthcare systems, strong pharmaceutical manufacturing capabilities, and well-developed transportation and cold-chain infrastructure provide a stable foundation for healthcare logistics activities across the region.

The U.K. healthcare logistics market is supported by the U.K. Government’s pandemic-preparedness strategy, which sets actions through 2030 to strengthen medicines-supply-chain resilience, including improving supplier-held buffer-stock compliance and broadening the supplier base to reduce the risk of future medicine shortages.

The Germany healthcare logistics market benefits from the Federal Statistical Office’s projection that the population aged 67 and above will reach at least 20.5 million by the end of the 2030s, increasing the long-term requirement for medicines, healthcare services, and associated distribution networks.

Healthcare Logistics Market Competitive Landscape

The healthcare logistics market is highly fragmented, with competition comprising global logistics providers, pharmaceutical distributors, healthcare-focused third-party logistics companies, cold-chain specialists, clinical-trial logistics providers, and specialized transportation and warehousing firms. The leading players in the healthcare logistics market are DHL Group, FedEx, United Parcel Service of America, Inc., CEVA Logistics, and Cencora, collectively accounting for approximately 22% of the global market.

Established players compete primarily on global network coverage, cold-chain infrastructure, regulatory compliance, service reliability, specialized warehousing, technology-enabled tracking, and integrated distribution capabilities, while emerging and regional players compete through niche healthcare services, flexible delivery models, localized networks, cost efficiency, specialized temperature-controlled solutions, and customized logistics support.

List of Key and Emerging Players in Healthcare Logistics Market

Alloga Ltd.
AmerisourceBergen Corporation
AWL INDIA
BOLLORE
CEVA Logistics
DHL Group
DSV
Expeditors International of Washington, Inc.
Farmasoft
FedEx
FM Logistics
GEODIS
NextPharma Logistics GmbH
NIPPON EXPRESS HOLDINGS
noatum logistics
SCHENKER
United Parcel Service of America, Inc.
Yusen Logistics Global Management Co., Ltd
Cencora

Key Industry Developments

June 2026
DHL Supply Chain expanded its healthcare logistics network by introducing advanced cold chain solutions, AI-enabled shipment tracking, and temperature-controlled transportation services for pharmaceuticals and medical devices.
April 2026
UPS Healthcare expanded its global healthcare logistics capabilities through new temperature-controlled distribution facilities and enhanced end-to-end visibility solutions for life sciences customers.
January 2026
Kuehne+Nagel expanded its healthcare logistics portfolio by strengthening pharmaceutical cold chain infrastructure and digital shipment monitoring capabilities across key global markets.

Report Scope

Segmentation

By Service 5
  • Transportation Services
  • Freight Forwarding Services
  • Warehousing and Distribution
  • Value-added Services
  • Others
By Industry 3
  • Pharmaceutical
  • Biopharmaceutical
  • Medical Devices
By Supply Chain 2
  • Cold Chain
  • Non-Cold Chain
By End User 4
  • Pharmaceutical & Biotechnological Companies
  • Medical Device Companies
  • Healthcare Facilities
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Alloga Ltd. · AmerisourceBergen Corporation · AWL INDIA · BOLLORE · CEVA Logistics
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The healthcare logistics market size is valued at USD 108.18 Billion in 2026 and is projected to reach USD 163.90 Billion by 2034, at a CAGR of 5.33% during the forecast period 2026-2034.

North America dominated the market with a share of 40.02% in 2025.

The leading players in this market are Alloga Ltd., AmerisourceBergen Corporation, AWL INDIA, BOLLORE, CEVA Logistics.

The healthcare logistics market is projected to grow at a CAGR of 5.33% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: